天弘医药创新A(010654)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
-48,409,306.31 |
372,527,018.10 |
181,545,602.40 |
-109,181,364.35 |
| 利息合计 |
297,936.02 |
641,419.34 |
223,252.26 |
373,837.10 |
| 其中:存款利息收入 |
222,376.92 |
569,775.96 |
223,252.26 |
373,837.10 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
75,559.10 |
71,643.38 |
- |
- |
| 投资收益合计 |
162,930,821.33 |
142,000,246.36 |
-21,458,102.86 |
-211,604,048.85 |
| 其中:股票投资收益 |
159,274,763.37 |
134,806,715.33 |
-26,654,549.54 |
-221,830,620.47 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
-2,417.24 |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
3,656,057.96 |
7,195,948.27 |
5,196,446.68 |
10,226,571.62 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-213,259,393.30 |
219,617,468.25 |
201,502,457.56 |
101,046,422.89 |
| 其他收入 |
1,621,329.64 |
10,267,884.15 |
1,277,995.44 |
1,002,424.51 |
| 费用 |
8,709,934.80 |
20,299,826.32 |
8,492,814.25 |
13,051,589.57 |
| 管理人报酬 |
6,071,138.31 |
14,287,718.10 |
6,074,826.17 |
9,545,459.69 |
| 基金托管费 |
1,214,227.61 |
2,857,543.62 |
1,214,965.26 |
1,909,091.93 |
| 销售服务费 |
1,283,569.12 |
2,877,173.90 |
1,076,147.01 |
1,365,297.48 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
140,999.76 |
277,390.70 |
126,875.81 |
231,740.47 |
| 利润总额 |
-57,119,241.11 |
352,227,191.78 |
173,052,788.15 |
-122,232,953.92 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年